Characterization of t cell receptor repertoire and anti-ro/SSA autoantibodies in relation to sialadenitis of NOD mice

Autoimmunity

Volumn 22, Issue 1, 1995, Pages 9-16

  Skarstein, Kathrine ^a   Wahren, Marie ^a   Zaura, Egija ^b   Hattori, Masakazu ^c   Jonsson, Roland ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b KAROLINSKA INSTITUTE   (Sweden)

^c JOSLIN DIABETES CENTER   (United States)

Author keywords

NOD; Ro SSA antibodies; Sialadenitis; TCR V

Indexed keywords

ANTIBODY; AUTOANTIBODY; CD11B ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; MONOCLONAL ANTIBODY; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ENZYME IMMUNOASSAY; FEMALE; GENE EXPRESSION; IMMUNOBLOTTING; LYMPH NODE; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; SALIVARY GLAND; SIALOADENITIS; T LYMPHOCYTE;

ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DIABETES MELLITUS, TYPE 1; FEMALE; MALE; MICE; MICE, INBRED NOD; RECEPTORS, ANTIGEN, T-CELL; RIBONUCLEOPROTEINS; RNA, SMALL CYTOPLASMIC; SJOGREN'S SYNDROME;

EID: 0029556327     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.3109/08916939508995294     Document Type: Article

References (44)

1. Breeding of non-obese, diabetic strain of mice
2. Ultrastructural and immunocytochemical aspects of lymphocytic submandibulitis in the non-obese diabetic (NOD) mouse
3. Sialadenitis in nonobese diabetic mice: Transfer into syngenic healthy neonates by splenic T lymphocytes
4. Utilization of the non-obese diabetic (NOD) mouse as an animal model for the study of secondary Sjögren's syndrome
5. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology
6. Characterization of antinuclear autoantibodies present in the serum from nonobese diabetic (NOD) mice
7. Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention
8. Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy
9. Restricted heterogeneity in T-cell antigen receptor Vβ gene usage in the lymph nodes and arthritic joints of mice
10. Therapy against murine collagene-induced arthritis with T cell receptor Vβ-specific antibodies
11. Evidence for the effects of a superantigen in rheumatoid arthritis
12. Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention
13. Oligoclonality of T cells in salivary glands of autoimmune MRL/lpr mice
14. MRL/lpr mice produce anti-Ro 52000 MW antibodies: detection, analysis of specificity and site of production
15. Sialdenitis in the MRL-1 mouse: Morphological and immunohistoehemical characterization of resident and infiltrating cells
16. +) subsets among anti-la cytolytic T cell clones
17. Xenogenic monoclonal antibodies to mouse lymphoid differentiation antigens
18. Mac-1: a macrophage differentiation antigen identified by monoclonal antibody
19. Characterization of a monoclonal antibody which detects all murine αβ T cell receptors
20. Intraepithelial lymphocytes: Anatomical site, not T cell receptor form, dictates phenotype and function
21. Surprisingly uneven distribution of the T cell receptor V beta repertoire in wild mice
22. d haplotype
23. Cytotoxic T-cell clone specific monoclonal antibodies used to select clonotypic antigen-specific cytotoxic T cells
24. 1
25. The antigen-specific, major histocompatibility complex-restricted receptor on T cells. VI. An antibody to a receptor allotype
26. + T cells
27. T-cell receptor-specific monoclonal antibodies against a Vβ11-positive mouse T-cell clone
28. Use of avidin-biotinperoxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures
29. Identification of antigenic regions of the human Ro 60 kDa protein using recombinant antigen and synthetic peptides
30. Identification of antigenic regions of the human 52 kD Ro/SS-A protein recognised by patient sera
31. Demonstration of an aminoterminal La epitope recognized by human anti-La sera
32. Antibody production by hybridomas
33. Characterization of pancreatic islet cell infiltrates in NOD mice: effect of cell transfer and transgene expression
34. T cell receptor V gene usage of islet β cell-reactive T cells is not restricted in non-obese diabetic mice
35. T-lymphocyte-receptor repertoire of infiltrating T lymphocytes into NOD mouse pancreas
36. Multiple TCR Vβ usage by infiltrates of young NOD mouse islets of Langerhans: A polymerase chain reaction analysis
37. Islet-specific T-cell clones from nonobese diabetic mice express heterogeneous T-cell receptors
38. Prevention of cyclophosphamide-induced diabetes by anti-Vβ8 T-lymphocyte-receptor monoclonal antibody therapy in NOD/wehi mice
39. Evidence for a preferential Vβ usage by the T cells which adoptively transfer diabetes in NOD mice
40. Anchored polymerase chain reaction based analysis of the Vβ repertoire in the non-obese diabetic (NOD) mouse
41. Altered expression of self-reactive T cell receptor Vβ regions in autoimmune mice
42. Short-term administration of anti-L3T4 moAb prevents diabetes in NOD mice
43. T-cell receptor V region β-chain gene expression in the autoimmune thyroiditis of non-obese diabetic mice
44. Mycobacteria precipitate an SLE-like syndrome in diabetes-prone NOD mice